EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma

Jiaying Wu, Wanying Liu, Yang Cao, Yang Yang, Zhen Shang, Mi Zhou, Yicheng Zhang, Fankai Meng, Xiaojian Zhu, Yi Xiao

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03855-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Jiaying Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou Dis…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Central Nervous System Neoplasms, Immunotherapy, Adoptive, Transplantation, Autologous. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationCentral Nervous System NeoplasmsImmunotherapy, AdoptiveTransplantation, AutologousHumansMaleFemaleMiddle AgedAdultRetrospective StudiesYoung AdultReceptors, Chimeric AntigenAgedTreatment OutcomeAdolescentNeoplasm Recurrence, LocalLymphomaCombined Modality TherapyFollow-Up Studies

Stichwörter der Autor:innen

Central nervous system lymphomaChimeric antigen receptorClinical outcomesImmunotherapyTransplantation

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. doctormeng@163.com.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. zhuxiaojian@hust.edu.cn.
  • Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095 Jiefang Avenue, Qiaokou District, Wuhan, 430030, Hubei, China. yixiao@tjh.tjmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wu, J., Liu, W., Cao, Y., Yang, Y., Shang, Z., Zhou, M., Zhang, Y., Meng, F., Zhu, X., & Xiao, Y. (2024). Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03855-7

Vancouver

Wu J, Liu W, Cao Y, Yang Y, Shang Z, Zhou M, et al. Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03855-7

BibTeX
@article{Wu2024,
  author = {Wu, Jiaying and Liu, Wanying and Cao, Yang and Yang, Yang and Shang, Zhen and Zhou, Mi and Zhang, Yicheng and Meng, Fankai and Zhu, Xiaojian and Xiao, Yi},
  title = {Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03855-7}
}
Kostenlos starten →